Global Metabolic Disorders Treatment Market Size, Status and Forecast 2020-2026

May 2020 | 99 pages | ID: G54CEB0B1952EN
QYResearch

Abstracts

This report focuses on the global Metabolic Disorders Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Metabolic Disorders Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Merck
• Novartis
• Takeda Pharmaceutical
• Astra Zeneca
• Boehringer Ingelheim
• KOWA
• Kythera
• Fuji yakuhin
• LG Life Science
• Metsubishi Tanabe Pharma

Market segment by Type, the product can be split into

• Glycogen Metabolism Disease Drug
• Lipid Metabolism Disease Drug
• Amino Acid Metabolism Drug
• Other

Market segment by Application, split into

• Hospital
• Retail Pharmacy

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Metabolic Disorders Treatment status, future forecast, growth opportunity, key market and key players.
• To present the Metabolic Disorders Treatment development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Metabolic Disorders Treatment are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Metabolic Disorders Treatment Revenue
1.4 Market Analysis by Type
  1.4.1 Global Metabolic Disorders Treatment Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Glycogen Metabolism Disease Drug
  1.4.3 Lipid Metabolism Disease Drug
  1.4.4 Amino Acid Metabolism Drug
  1.4.5 Other
1.5 Market by Application
  1.5.1 Global Metabolic Disorders Treatment Market Share by Application: 2020 VS 2026
  1.5.2 Hospital
  1.5.3 Retail Pharmacy
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Metabolic Disorders Treatment Market Perspective (2015-2026)
2.2 Metabolic Disorders Treatment Growth Trends by Regions
  2.2.1 Metabolic Disorders Treatment Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Metabolic Disorders Treatment Historic Market Share by Regions (2015-2020)
  2.2.3 Metabolic Disorders Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Metabolic Disorders Treatment Market Growth Strategy
  2.3.6 Primary Interviews with Key Metabolic Disorders Treatment Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Metabolic Disorders Treatment Players by Market Size
  3.1.1 Global Top Metabolic Disorders Treatment Players by Revenue (2015-2020)
  3.1.2 Global Metabolic Disorders Treatment Revenue Market Share by Players (2015-2020)
  3.1.3 Global Metabolic Disorders Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Metabolic Disorders Treatment Market Concentration Ratio
  3.2.1 Global Metabolic Disorders Treatment Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Metabolic Disorders Treatment Revenue in 2019
3.3 Metabolic Disorders Treatment Key Players Head office and Area Served
3.4 Key Players Metabolic Disorders Treatment Product Solution and Service
3.5 Date of Enter into Metabolic Disorders Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Metabolic Disorders Treatment Historic Market Size by Type (2015-2020)
4.2 Global Metabolic Disorders Treatment Forecasted Market Size by Type (2021-2026)

5 METABOLIC DISORDERS TREATMENT BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Metabolic Disorders Treatment Market Size by Application (2015-2020)
5.2 Global Metabolic Disorders Treatment Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Metabolic Disorders Treatment Market Size (2015-2020)
6.2 Metabolic Disorders Treatment Key Players in North America (2019-2020)
6.3 North America Metabolic Disorders Treatment Market Size by Type (2015-2020)
6.4 North America Metabolic Disorders Treatment Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Metabolic Disorders Treatment Market Size (2015-2020)
7.2 Metabolic Disorders Treatment Key Players in Europe (2019-2020)
7.3 Europe Metabolic Disorders Treatment Market Size by Type (2015-2020)
7.4 Europe Metabolic Disorders Treatment Market Size by Application (2015-2020)

8 CHINA

8.1 China Metabolic Disorders Treatment Market Size (2015-2020)
8.2 Metabolic Disorders Treatment Key Players in China (2019-2020)
8.3 China Metabolic Disorders Treatment Market Size by Type (2015-2020)
8.4 China Metabolic Disorders Treatment Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Metabolic Disorders Treatment Market Size (2015-2020)
9.2 Metabolic Disorders Treatment Key Players in Japan (2019-2020)
9.3 Japan Metabolic Disorders Treatment Market Size by Type (2015-2020)
9.4 Japan Metabolic Disorders Treatment Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Metabolic Disorders Treatment Market Size (2015-2020)
10.2 Metabolic Disorders Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Metabolic Disorders Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Metabolic Disorders Treatment Market Size by Application (2015-2020)

11 INDIA

11.1 India Metabolic Disorders Treatment Market Size (2015-2020)
11.2 Metabolic Disorders Treatment Key Players in India (2019-2020)
11.3 India Metabolic Disorders Treatment Market Size by Type (2015-2020)
11.4 India Metabolic Disorders Treatment Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Metabolic Disorders Treatment Market Size (2015-2020)
12.2 Metabolic Disorders Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Metabolic Disorders Treatment Market Size by Type (2015-2020)
12.4 Central & South America Metabolic Disorders Treatment Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Merck
  13.1.1 Merck Company Details
  13.1.2 Merck Business Overview and Its Total Revenue
  13.1.3 Merck Metabolic Disorders Treatment Introduction
  13.1.4 Merck Revenue in Metabolic Disorders Treatment Business (2015-2020))
  13.1.5 Merck Recent Development
13.2 Novartis
  13.2.1 Novartis Company Details
  13.2.2 Novartis Business Overview and Its Total Revenue
  13.2.3 Novartis Metabolic Disorders Treatment Introduction
  13.2.4 Novartis Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.2.5 Novartis Recent Development
13.3 Takeda Pharmaceutical
  13.3.1 Takeda Pharmaceutical Company Details
  13.3.2 Takeda Pharmaceutical Business Overview and Its Total Revenue
  13.3.3 Takeda Pharmaceutical Metabolic Disorders Treatment Introduction
  13.3.4 Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.3.5 Takeda Pharmaceutical Recent Development
13.4 Astra Zeneca
  13.4.1 Astra Zeneca Company Details
  13.4.2 Astra Zeneca Business Overview and Its Total Revenue
  13.4.3 Astra Zeneca Metabolic Disorders Treatment Introduction
  13.4.4 Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.4.5 Astra Zeneca Recent Development
13.5 Boehringer Ingelheim
  13.5.1 Boehringer Ingelheim Company Details
  13.5.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.5.3 Boehringer Ingelheim Metabolic Disorders Treatment Introduction
  13.5.4 Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.5.5 Boehringer Ingelheim Recent Development
13.6 KOWA
  13.6.1 KOWA Company Details
  13.6.2 KOWA Business Overview and Its Total Revenue
  13.6.3 KOWA Metabolic Disorders Treatment Introduction
  13.6.4 KOWA Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.6.5 KOWA Recent Development
13.7 Kythera
  13.7.1 Kythera Company Details
  13.7.2 Kythera Business Overview and Its Total Revenue
  13.7.3 Kythera Metabolic Disorders Treatment Introduction
  13.7.4 Kythera Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.7.5 Kythera Recent Development
13.8 Fuji yakuhin
  13.8.1 Fuji yakuhin Company Details
  13.8.2 Fuji yakuhin Business Overview and Its Total Revenue
  13.8.3 Fuji yakuhin Metabolic Disorders Treatment Introduction
  13.8.4 Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.8.5 Fuji yakuhin Recent Development
13.9 LG Life Science
  13.9.1 LG Life Science Company Details
  13.9.2 LG Life Science Business Overview and Its Total Revenue
  13.9.3 LG Life Science Metabolic Disorders Treatment Introduction
  13.9.4 LG Life Science Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.9.5 LG Life Science Recent Development
13.10 Metsubishi Tanabe Pharma
  13.10.1 Metsubishi Tanabe Pharma Company Details
  13.10.2 Metsubishi Tanabe Pharma Business Overview and Its Total Revenue
  13.10.3 Metsubishi Tanabe Pharma Metabolic Disorders Treatment Introduction
  13.10.4 Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2015-2020)
  13.10.5 Metsubishi Tanabe Pharma Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Metabolic Disorders Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Metabolic Disorders Treatment Revenue
Table 3. Ranking of Global Top Metabolic Disorders Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Metabolic Disorders Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Glycogen Metabolism Disease Drug
Table 6. Key Players of Lipid Metabolism Disease Drug
Table 7. Key Players of Amino Acid Metabolism Drug
Table 8. Key Players of Other
Table 9. Global Metabolic Disorders Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Metabolic Disorders Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Metabolic Disorders Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Metabolic Disorders Treatment Market Share by Regions (2015-2020)
Table 13. Global Metabolic Disorders Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Metabolic Disorders Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Metabolic Disorders Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Metabolic Disorders Treatment Players
Table 20. Global Metabolic Disorders Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Metabolic Disorders Treatment Market Share by Players (2015-2020)
Table 22. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Disorders Treatment as of 2019)
Table 23. Global Metabolic Disorders Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Metabolic Disorders Treatment Product Solution and Service
Table 26. Date of Enter into Metabolic Disorders Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Metabolic Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Metabolic Disorders Treatment Market Size Share by Type (2015-2020)
Table 30. Global Metabolic Disorders Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Metabolic Disorders Treatment Market Size Share by Application (2015-2020)
Table 32. Global Metabolic Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Metabolic Disorders Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Metabolic Disorders Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Metabolic Disorders Treatment Market Share (2019-2020)
Table 36. North America Metabolic Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Metabolic Disorders Treatment Market Share by Type (2015-2020)
Table 38. North America Metabolic Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Metabolic Disorders Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Metabolic Disorders Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Metabolic Disorders Treatment Market Share (2019-2020)
Table 42. Europe Metabolic Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Metabolic Disorders Treatment Market Share by Type (2015-2020)
Table 44. Europe Metabolic Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Metabolic Disorders Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Metabolic Disorders Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Metabolic Disorders Treatment Market Share (2019-2020)
Table 48. China Metabolic Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Metabolic Disorders Treatment Market Share by Type (2015-2020)
Table 50. China Metabolic Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Metabolic Disorders Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Metabolic Disorders Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Metabolic Disorders Treatment Market Share (2019-2020)
Table 54. Japan Metabolic Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Metabolic Disorders Treatment Market Share by Type (2015-2020)
Table 56. Japan Metabolic Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Metabolic Disorders Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Metabolic Disorders Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Metabolic Disorders Treatment Market Share (2019-2020)
Table 60. Southeast Asia Metabolic Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Metabolic Disorders Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Metabolic Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Metabolic Disorders Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Metabolic Disorders Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Metabolic Disorders Treatment Market Share (2019-2020)
Table 66. India Metabolic Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Metabolic Disorders Treatment Market Share by Type (2015-2020)
Table 68. India Metabolic Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Metabolic Disorders Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Metabolic Disorders Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Metabolic Disorders Treatment Market Share (2019-2020)
Table 72. Central & South America Metabolic Disorders Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Metabolic Disorders Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Metabolic Disorders Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Metabolic Disorders Treatment Market Share by Application (2015-2020)
Table 76. Merck Company Details
Table 77. Merck Business Overview
Table 78. Merck Product
Table 79. Merck Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 80. Merck Recent Development
Table 81. Novartis Company Details
Table 82. Novartis Business Overview
Table 83. Novartis Product
Table 84. Novartis Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 85. Novartis Recent Development
Table 86. Takeda Pharmaceutical Company Details
Table 87. Takeda Pharmaceutical Business Overview
Table 88. Takeda Pharmaceutical Product
Table 89. Takeda Pharmaceutical Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 90. Takeda Pharmaceutical Recent Development
Table 91. Astra Zeneca Company Details
Table 92. Astra Zeneca Business Overview
Table 93. Astra Zeneca Product
Table 94. Astra Zeneca Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 95. Astra Zeneca Recent Development
Table 96. Boehringer Ingelheim Company Details
Table 97. Boehringer Ingelheim Business Overview
Table 98. Boehringer Ingelheim Product
Table 99. Boehringer Ingelheim Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 100. Boehringer Ingelheim Recent Development
Table 101. KOWA Company Details
Table 102. KOWA Business Overview
Table 103. KOWA Product
Table 104. KOWA Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 105. KOWA Recent Development
Table 106. Kythera Company Details
Table 107. Kythera Business Overview
Table 108. Kythera Product
Table 109. Kythera Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 110. Kythera Recent Development
Table 111. Fuji yakuhin Business Overview
Table 112. Fuji yakuhin Product
Table 113. Fuji yakuhin Company Details
Table 114. Fuji yakuhin Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 115. Fuji yakuhin Recent Development
Table 116. LG Life Science Company Details
Table 117. LG Life Science Business Overview
Table 118. LG Life Science Product
Table 119. LG Life Science Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 120. LG Life Science Recent Development
Table 121. Metsubishi Tanabe Pharma Company Details
Table 122. Metsubishi Tanabe Pharma Business Overview
Table 123. Metsubishi Tanabe Pharma Product
Table 124. Metsubishi Tanabe Pharma Revenue in Metabolic Disorders Treatment Business (2015-2020) (Million US$)
Table 125. Metsubishi Tanabe Pharma Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Metabolic Disorders Treatment Market Share by Type: 2020 VS 2026
Figure 2. Glycogen Metabolism Disease Drug Features
Figure 3. Lipid Metabolism Disease Drug Features
Figure 4. Amino Acid Metabolism Drug Features
Figure 5. Other Features
Figure 6. Global Metabolic Disorders Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Metabolic Disorders Treatment Report Years Considered
Figure 10. Global Metabolic Disorders Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 11. Global Metabolic Disorders Treatment Market Share by Regions: 2020 VS 2026
Figure 12. Global Metabolic Disorders Treatment Market Share by Regions (2021-2026)
Figure 13. Porter's Five Forces Analysis
Figure 14. Global Metabolic Disorders Treatment Market Share by Players in 2019
Figure 15. Global Top Metabolic Disorders Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metabolic Disorders Treatment as of 2019
Figure 16. The Top 10 and 5 Players Market Share by Metabolic Disorders Treatment Revenue in 2019
Figure 17. North America Metabolic Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Europe Metabolic Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. China Metabolic Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Japan Metabolic Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Southeast Asia Metabolic Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. India Metabolic Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Central & South America Metabolic Disorders Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Merck Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 26. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Novartis Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 28. Takeda Pharmaceutical Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Takeda Pharmaceutical Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 30. Astra Zeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Astra Zeneca Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 32. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Boehringer Ingelheim Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 34. KOWA Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. KOWA Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 36. Kythera Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Kythera Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 38. Fuji yakuhin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Fuji yakuhin Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 40. LG Life Science Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. LG Life Science Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 42. Metsubishi Tanabe Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Metsubishi Tanabe Pharma Revenue Growth Rate in Metabolic Disorders Treatment Business (2015-2020)
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed